2od1
From Proteopedia
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
| - | AML1/ETO results from the t(8;21) associated with 12%-15% of acute myeloid | + | AML1/ETO results from the t(8;21) associated with 12%-15% of acute myeloid leukemia. The AML1/ETO MYND domain mediates interactions with the corepressors SMRT and N-CoR and contributes to AML1/ETO's ability to repress proliferation and differentiation of primary bone marrow cells as well as to enhance their self renewal in vitro. We solved the solution structure of the MYND domain and show it to be structurally homologous to the PHD and RING finger families of proteins. We also determined the solution structure of an MYND-SMRT peptide complex. We demonstrated that a single amino acid substitution that disrupts the interaction between the MYND domain and the SMRT peptide attenuated AML1/ETO's effects on proliferation, differentiation, and gene expression. |
==About this Structure== | ==About this Structure== | ||
| Line 13: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| - | [[Category: Bushweller, J | + | [[Category: Bushweller, J H.]] |
[[Category: Chen, W.]] | [[Category: Chen, W.]] | ||
| - | [[Category: Cheney, M | + | [[Category: Cheney, M D.]] |
[[Category: Cierpicki, T.]] | [[Category: Cierpicki, T.]] | ||
[[Category: Gaudet, J.]] | [[Category: Gaudet, J.]] | ||
[[Category: Hartman, K.]] | [[Category: Hartman, K.]] | ||
| - | [[Category: Klet, R | + | [[Category: Klet, R C.]] |
| - | [[Category: Laue, T | + | [[Category: Laue, T M.]] |
| - | [[Category: Liu, Y | + | [[Category: Liu, Y Z.]] |
[[Category: Roudaia, L.]] | [[Category: Roudaia, L.]] | ||
| - | [[Category: Speck, N | + | [[Category: Speck, N A.]] |
[[Category: ZN]] | [[Category: ZN]] | ||
[[Category: cross-braced topology]] | [[Category: cross-braced topology]] | ||
[[Category: zinc finger]] | [[Category: zinc finger]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:17:06 2008'' |
Revision as of 16:17, 21 February 2008
|
Solution structure of the MYND domain from human AML1-ETO
Overview
AML1/ETO results from the t(8;21) associated with 12%-15% of acute myeloid leukemia. The AML1/ETO MYND domain mediates interactions with the corepressors SMRT and N-CoR and contributes to AML1/ETO's ability to repress proliferation and differentiation of primary bone marrow cells as well as to enhance their self renewal in vitro. We solved the solution structure of the MYND domain and show it to be structurally homologous to the PHD and RING finger families of proteins. We also determined the solution structure of an MYND-SMRT peptide complex. We demonstrated that a single amino acid substitution that disrupts the interaction between the MYND domain and the SMRT peptide attenuated AML1/ETO's effects on proliferation, differentiation, and gene expression.
About this Structure
2OD1 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.
Reference
Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity., Liu Y, Chen W, Gaudet J, Cheney MD, Roudaia L, Cierpicki T, Klet RC, Hartman K, Laue TM, Speck NA, Bushweller JH, Cancer Cell. 2007 Jun;11(6):483-97. PMID:17560331
Page seeded by OCA on Thu Feb 21 18:17:06 2008
